Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
3.275
-0.255 (-7.22%)
Sep 29, 2026, 11:37 AM EDT - Market open
Inventiva Revenue
Inventiva had revenue of 1.31M EUR in the half year ending June 30, 2026, a decrease of -52.23%. This brings the company's revenue in the last twelve months to 3.62M, down -75.47% year-over-year. In the year 2025, Inventiva had annual revenue of 7.93M, down -46.17%.
Revenue (ttm)
3.62M EUR
Revenue Growth
-75.47%
P/S Ratio
282.81
Revenue / Employee
47,039 EUR
Employees
77
Market Cap
793.87M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.93M | -6.80M | -46.17% |
| Dec 31, 2024 | 14.72M | -8.44M | -36.43% |
| Dec 31, 2023 | 23.16M | 4.35M | 23.12% |
| Dec 31, 2022 | 18.81M | 10.31M | 121.32% |
| Dec 31, 2021 | 8.50M | 3.24M | 61.52% |
| Dec 31, 2020 | 5.26M | -6.03M | -53.39% |
| Dec 31, 2019 | 11.29M | 3.91M | 53.02% |
| Dec 31, 2018 | 7.38M | -2.58M | -25.90% |
| Dec 31, 2017 | 9.96M | -4.39M | -30.61% |
| Dec 31, 2016 | 14.35M | 5.69M | 65.66% |
| Dec 31, 2015 | 8.66M | 2.36M | 37.55% |
| Dec 31, 2014 | 6.30M | 1.20M | 23.46% |
| Dec 31, 2013 | 5.10M | 5.06M | 10,977.18% |
| Dec 31, 2012 | 46.06K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Pharming Group | 366.48M |
| Geron | 204.56M |
| 4D Molecular Therapeutics | 92.01M |
| Aclaris Therapeutics | 8.22M |
| Attovia Therapeutics | 1.80M |
IVA News
- 5 hours ago - Inventiva price target raised to $21 from $20 at Canaccord - TheFly
- 1 day ago - Inventiva Q2 Earnings Call Highlights - MarketBeat
- 1 day ago - Inventiva Earnings Call Transcript: Q2 2026 - Transcripts
- 1 day ago - Inventiva Earnings release: Q2 2026 - Filings
- 1 day ago - Inventiva Slides: Q2 2026 - Filings
- 1 day ago - Inventiva Quarterly report: Q2 2026 - Filings
- 1 day ago - Inventiva Reports Unaudited 2026 First-Half Financial Results and Provides Corporate Update - GlobeNewsWire
- 13 days ago - Inventiva SA at Morgan Stanley Global Healthcare Conference Transcript - GuruFocus